borderline significantp = .067
Non‐responders showed a borderline significant increase in the composite endpoint compared with responders at 6 months (5 [15.2%] vs 0 [0%], p = .067) and at 12 months (9 [28.1%] vs 2 [8.7%], p = .097) (Table 3 ). 4.
Non‐responders showed a borderline significant increase in the composite endpoint compared with responders at 6 months (5 [15.2%] vs 0 [0%], p = .067) and at 12 months (9 [28.1%] vs 2 [8.7%], p = .097) (Table 3 ). 4.